- The trend backdrop is active with a 1-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
ROGP
VIE
Week ended 07 Aug 2026
Weekly Investor Report
ROCHE HOLDING AG PS · Healthcare · Drug Manufacturers - General
Latest close
397.0 EUR
4.2%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 9.1% above the Trend Line and sits at 97.9% of its 52-week range. The latest completed week returned 4.2%, after a 8.8% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: price is close to its 52-week high.
Setup score
56
out of 100
Latest Close
397.0 EUR
7 Aug 2026
1W Return
4.2%
latest completed week
4W Return
8.8%
short-term follow-through
12W Return
11.5%
quarterly tape
Trend Breadth
55.8%
29 of 52 weeks active
Volume Ratio
-
vs 13-week average
- 2 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
Price follow-through
4.2%
Latest completed week; four-week move 8.8%.
Indicator stack
34/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 9.1% above the Trend Line and sits at 97.9% of its 52-week range. The latest completed week returned 4.2%, after a 8.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is - the 13-week average. Participation data is incomplete.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.7612-week average 0.63
12-week confirmation
Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.76Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 8.8% over four weeks, 11.5% over 12 weeks, and 55.7% over one year. The current trend has remained active for 1 consecutive weeks.
Performance by holding period
Active trend streak1 weeks
Active weeks in one year29
Trend breadth55.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.68Latest activity-pressure read.
Pressure change1573.6%Four-week change in activity pressure.
Leadership-3.53Latest relative-leadership reading.
RS change60.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-0.8%Distance below the 52-week high.
13-week volatility2.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2613 weeks finished lower.
Best week+5.8%Week of 26 Jun.
Worst week-7.1%Week of 6 Mar.
Latest week+4.2%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains8
Flat weeks2
Modest losses12
Sharp losses1
Recent vol2.9%13-week weekly-return volatility.
Base vol3.5%52-week weekly-return volatility.
Up/down split28/22Count of positive and negative weeks in the 52-week window.
Average skew3.3% / -2.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAT Healthcare
4-week rank23 / 100
Group average2.6%
Trend breadth47.0%
Trend47.0%active weekly trend signals
MD73.0%positive activity pressure
RS10.0%positive relative leadership
Four-week leaders
IndustryAT Drug Manufacturers - General
4-week rank5 / 17
Group average3.5%
Trend breadth70.6%
Trend70.6%active weekly trend signals
MD88.2%positive activity pressure
RS11.8%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape53/100
Trend, activity pressure, participation, and risk combine to a 53/100 tape read.
Indicator analysis36/100Latest 12-week confirmation: trend 5/12, activity pressure 4/12, relative leadership 0/12.
Activity pressure 0.76; 2 reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Half Year 2026 Roche Holding AG Earnings Call Transcript Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 397.0 EUR | 4.2% | 364.0 EUR | 324.1 EUR | 0.68 | -3.53 | 0 | On |
| 31 Jul 2026 | 381.0 EUR | -0.3% | 362.6 EUR | 322.9 EUR | 0.48 | -4.46 | 0 | Off |
| 24 Jul 2026 | 382.0 EUR | 5.5% | 361.4 EUR | 322.0 EUR | 0.39 | -4.14 | 50 | Off |
| 17 Jul 2026 | 362.0 EUR | -0.8% | 360.2 EUR | 321.0 EUR | 0.15 | -7.87 | 0 | Off |
| 10 Jul 2026 | 365.0 EUR | -1.4% | 359.4 EUR | 320.4 EUR | -0.05 | -8.92 | 0 | Off |
| 3 Jul 2026 | 370.0 EUR | 1.4% | 358.2 EUR | 319.6 EUR | -0.19 | -8.91 | 0 | Off |
| 26 Jun 2026 | 365.0 EUR | 5.8% | 356.7 EUR | 318.8 EUR | -0.43 | -8.06 | 0 | Off |
| 19 Jun 2026 | 345.0 EUR | -3.6% | 355.3 EUR | 318.0 EUR | -0.60 | -14.83 | 0 | Off |
| 12 Jun 2026 | 358.0 EUR | 0.6% | 354.7 EUR | 317.5 EUR | -0.57 | -8.08 | 0 | On |
| 5 Jun 2026 | 356.0 EUR | -1.4% | 352.8 EUR | 316.8 EUR | -0.59 | -6.18 | 0 | On |
| 29 May 2026 | 361.0 EUR | -1.6% | 350.3 EUR | 316.0 EUR | -0.59 | -5.98 | 3 | On |
| 22 May 2026 | 367.0 EUR | 3.1% | 347.4 EUR | 315.2 EUR | -0.66 | -1.87 | 0 | On |
| 15 May 2026 | 356.0 EUR | 3.2% | 344.6 EUR | 314.2 EUR | -0.74 | -2.81 | 27 | On |
| 8 May 2026 | 345.0 EUR | -0.3% | 342.7 EUR | 313.4 EUR | -0.85 | -6.20 | 18 | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.